Concepedia

Patrick Squiban

PS

Statistics

Publications

16

Citations

1.1K

H-Index

15

Active since

1997

Affiliations

Transgene (France)(Current)

Inserm

Kantonsspital Baselland

Sorbonne Université

UPMC Hillman Cancer Center

Patrick Squiban is an author at Transgene (France) specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1997–2009

16

Publications

16

Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study

DE Bernstein, L. Jeffers, Elisabeth Erhardtsen et al. · Gastroenterology · 1997 · 254 citations

, , +17

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen‐specific immunotherapy in patients with MUC1‐positive advanced cancer

Christoph Rochlitz, Robert A. Figlin, Patrick Squiban et al. · The Journal of Gene Medicine · 2003 · 172 citations

, , +16

Phase I Study of Dystrophin Plasmid-Based Gene Therapy in Duchenne/Becker Muscular Dystrophy

Norma B. Romero, Serge Braun, Olivier Benvéniste et al. · Human Gene Therapy · 2004 · 149 citations

, , +17

Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas

Reinhard Dummer, Jessica C. Hassel, Friederike Fellenberg et al. · Blood · 2004 · 104 citations

, , +12

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Robert Dreicer, Walter M. Stadler, F. R. Ahmann et al. · Investigational New Drugs · 2008 · 80 citations

, , +15

1–5 of 16